Meta Platforms
Long

Meta Platforms (NASDAQ: META) Receives Analyst Upgrade

215
Meta Platforms (NASDAQ: META) is set to report first-quarter 2025 results on April 30. Ahead of the release, the stock is trading at $532.16, down over 18% year-to-date. Concerns about a pullback in ad spending and rising AI infrastructure costs had weighed heavily on investor sentiment. However, robust engagement trends and a notably cheaper 16x EV/EBIT valuation have prompted a shift in outlook. The stock has been upgraded from Sell to Hold.

Despite macroeconomic challenges and regulatory fines from the EU, analysts maintain a positive long-term view. Benchmark’s Mark Zgutowicz cut his price target to $640 from $820 but reaffirmed a Buy rating. He highlighted Meta’s long-term strength in U.S. digital ad markets and its disciplined capital allocation.

Similarly, Stifel’s Mark Kelley reduced his target to $628, citing cautiousness in the e-commerce and subscriptions space. He acknowledged market discomfort reminiscent of the COVID-19 era.

Meanwhile, Monness’s Brian White maintained a Buy rating with a $775 target, projecting Q1 revenue of $41.73 billion and earnings of $5.54 per share. Analysts, on average, expect EPS of $5.24 and revenue of $41.3 billion, suggesting double-digit growth. The stock holds a Strong Buy consensus from Wall Street. Out of 46 analysts, 42 rate it Buy, three Hold, and one Sell. The average price target of $705 implies a potential 35.5% upside from current levels.

Technical Analysis

META has rebounded sharply off a key ascending trendline support that dates back to April 2024. The recent recovery from around $475 coincided with the ascending trendline. The price has been bullish overall, as seen from the 200-day moving average at $408.64.

Price is now about to reclaim both the 100-day ($549.11) and 50-day ($601.58) moving averages. The chart indicates a possible near-term pullback followed by a push toward the $740.91 high. Volume is currently at 44.25 million shares, suggesting rising interest.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.